Literature DB >> 23300041

MR imaging of renal cortical tumours: qualitative and quantitative chemical shift imaging parameters.

Christoph A Karlo1, Olivio F Donati, Irene A Burger, Junting Zheng, Chaya S Moskowitz, Hedvig Hricak, Oguz Akin.   

Abstract

OBJECTIVES: To assess qualitative and quantitative chemical shift MRI parameters of renal cortical tumours.
METHODS: A total of 251 consecutive patients underwent 1.5-T MRI before nephrectomy. Two readers (R1, R2) independently evaluated all tumours visually for a decrease in signal intensity (SI) on opposed- compared with in-phase chemical shift images. In addition, SI was measured on in- and opposed-phase images (SI(IP), SI(OP)) and the chemical shift index was calculated as a measure of percentage SI change. Histopathology served as the standard of reference.
RESULTS: A visual decrease in SI was identified significantly more often in clear cell renal cell carcinoma (RCCs) (R1, 73 %; R2, 64 %) and angiomyolipomas (both, 80 %) than in oncocytomas (29 %, 12 %), papillary (29 %, 17 %) and chromophobe RCCs (13 %, 9 %; all, P < 0.05). Median chemical shift index was significantly greater in clear cell RCC and angiomyolipoma than in the other histological subtypes (both, P < 0.001). Interobserver agreement was fair for visual (kappa, 0.4) and excellent for quantitative analysis (concordance correlation coefficient, 0.80).
CONCLUSIONS: A decrease in SI on opposed-phase chemical shift images is not an identifying feature of clear cell RCCs or angiomyolipomas, but can also be observed in oncocytomas, papillary and chromophobe RCCs. After excluding angiomyolipomas, a decrease in SI of more than 25 % was diagnostic for clear cell RCCs. KEY POINTS: • Chemical shift MRI offers new information about fat within renal tumours. • Opposed-phase signal decrease can be observed in all renal cortical tumours. • A greater than 25 % decrease in signal appears to be diagnostic for clear cell RCCs.

Entities:  

Mesh:

Year:  2013        PMID: 23300041     DOI: 10.1007/s00330-012-2758-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  17 in total

1.  Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation.

Authors:  Fumito Fujiyoshi; Masayuki Nakajo; Yoshihiko Fukukura; Shinsaku Tsuchimochi
Journal:  AJR Am J Roentgenol       Date:  2003-06       Impact factor: 3.959

Review 2.  Pathologic features of renal cortical tumors.

Authors:  Satish K Tickoo; Anuradha Gopalan
Journal:  Urol Clin North Am       Date:  2008-11       Impact factor: 2.241

Review 3.  Differential diagnosis of renal tumours with clear cell histology.

Authors:  Victor E Reuter; Satish K Tickoo
Journal:  Pathology       Date:  2010-06       Impact factor: 5.306

Review 4.  The pathology of renal epithelial neoplasms.

Authors:  Victor E Reuter
Journal:  Semin Oncol       Date:  2006-10       Impact factor: 4.929

5.  Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging.

Authors:  Jeong Kon Kim; Soo Hyun Kim; Yoon Jin Jang; Hanjong Ahn; Choung-Soo Kim; Hyungkeun Park; Jun Woo Lee; Suk Kim; Kyoung-Sik Cho
Journal:  Radiology       Date:  2006-02-28       Impact factor: 11.105

6.  The use of opposed-phase chemical shift MRI in the diagnosis of renal angiomyolipomas.

Authors:  Gary M Israel; Nicole Hindman; Elizabeth Hecht; Glenn Krinsky
Journal:  AJR Am J Roentgenol       Date:  2005-06       Impact factor: 3.959

7.  Papillary renal carcinoma: diagnostic approach by chemical shift gradient-echo and echo-planar MR imaging.

Authors:  Kengo Yoshimitsu; Daisuke Kakihara; Hiroyuki Irie; Tsuyoshi Tajima; Akihiro Nishie; Yoshiki Asayama; Masakazu Hirakawa; Tomohiro Nakayama; Seiji Naito; Hiroshi Honda
Journal:  J Magn Reson Imaging       Date:  2006-03       Impact factor: 4.813

8.  Chemical shift GRE MRI of renal angiomyolipoma.

Authors:  T Kido; Y Yamashita; S Sumi; Y Baba; M Takahashi; Y Ootsuka; S Ueda
Journal:  J Comput Assist Tomogr       Date:  1997 Mar-Apr       Impact factor: 1.826

9.  Fatty liver. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans.

Authors:  D G Mitchell; I Kim; T S Chang; S Vinitski; P M Consigny; S A Saponaro; S M Ehrlich; M D Rifkin; R Rubin
Journal:  Invest Radiol       Date:  1991-12       Impact factor: 6.016

10.  Benign adrenocortical masses: diagnosis with chemical shift MR imaging.

Authors:  D G Mitchell; M Crovello; T Matteucci; R O Petersen; M M Miettinen
Journal:  Radiology       Date:  1992-11       Impact factor: 11.105

View more
  23 in total

Review 1.  Renal angiomyolipoma without visible fat: Can we make the diagnosis using CT and MRI?

Authors:  Robert S Lim; Trevor A Flood; Matthew D F McInnes; Luke T Lavallee; Nicola Schieda
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

2.  MRI evaluation of small (<4cm) solid renal masses: multivariate modeling improves diagnostic accuracy for angiomyolipoma without visible fat compared to univariate analysis.

Authors:  Nicola Schieda; Marc Dilauro; Bardia Moosavi; Taryn Hodgdon; Gregory O Cron; Matthew D F McInnes; Trevor A Flood
Journal:  Eur Radiol       Date:  2015-10-20       Impact factor: 5.315

Review 3.  Dual energy MDCT assessment of renal lesions: an overview.

Authors:  Achille Mileto; Daniele Marin; Rendon C Nelson; Giorgio Ascenti; Daniel T Boll
Journal:  Eur Radiol       Date:  2013-10-04       Impact factor: 5.315

4.  Angiomyolipoma (AML) without visible fat: Ultrasound, CT and MR imaging features with pathological correlation.

Authors:  Shaheed W Hakim; Nicola Schieda; Taryn Hodgdon; Matthew D F McInnes; Marc Dilauro; Trevor A Flood
Journal:  Eur Radiol       Date:  2015-06-03       Impact factor: 5.315

Review 5.  Review of renal cell carcinoma and its common subtypes in radiology.

Authors:  Gavin Low; Guan Huang; Winnie Fu; Zaahir Moloo; Safwat Girgis
Journal:  World J Radiol       Date:  2016-05-28

Review 6.  Chemical shift magnetic resonance imaging for distinguishing minimal-fat renal angiomyolipoma from renal cell carcinoma: a meta-analysis.

Authors:  Ling-Shan Chen; Zheng-Qiu Zhu; Zhi-Tao Wang; Jing Li; Li-Feng Liang; Ji-Yang Jin; Zhong-Qiu Wang
Journal:  Eur Radiol       Date:  2017-11-24       Impact factor: 5.315

7.  Differentiation of Clear Cell Renal Cell Carcinoma From Other Renal Cortical Tumors by Use of a Quantitative Multiparametric MRI Approach.

Authors:  Andreas M Hötker; Yousef Mazaheri; Andreas Wibmer; Christoph A Karlo; Junting Zheng; Chaya S Moskowitz; Satish K Tickoo; Paul Russo; Hedvig Hricak; Oguz Akin
Journal:  AJR Am J Roentgenol       Date:  2017-01-17       Impact factor: 3.959

Review 8.  Correlating Preoperative Imaging with Histologic Subtypes of Renal Cell Carcinoma and Common Mimickers.

Authors:  Jennifer Gordetsky; Jessica Zarzour
Journal:  Curr Urol Rep       Date:  2016-07       Impact factor: 3.092

9.  Renal and adrenal masses containing fat at MRI: Proposed nomenclature by the society of abdominal radiology disease-focused panel on renal cell carcinoma.

Authors:  Nicola Schieda; Matthew S Davenport; Ivan Pedrosa; Atul Shinagare; Hersch Chandarana; Nicole Curci; Ankur Doshi; Gary Israel; Erick Remer; Jane Wang; Stuart G Silverman
Journal:  J Magn Reson Imaging       Date:  2019-01-28       Impact factor: 4.813

10.  Comparison of MRI features in lipid-rich and lipid-poor adrenal adenomas using subjective and quantitative analysis.

Authors:  Wendy Tu; Rosalind Gerson; Jorge Abreu-Gomez; Amar Udare; Rachel Mcphedran; Nicola Schieda
Journal:  Abdom Radiol (NY)       Date:  2021-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.